Alzheimer's disease

News

Startup Neuroglee raises $10m for virtual neurology clinics

A digital health company focusing on neurodegenerative disorders – Neuroglee Therapeutics – has raised $10 million in first-round funding to roll out a virtual neurology clinics for people

News

Biogen admits slow Aduhelm launch, as scientists question la...

Shares in Biogen have come under pressure after chief executive Michel Vounatsos admitted that the company is facing a much slower than anticipated rollout of its controversial Alzheimer's

News

Concept of memory loss and brain aging due to dementia and alzheimer's disease as a medical icon with fall trees shaped as a human head losing leaves with 3D illustration elements.

AC Immune claims half a win for tau drug in Alzheimer's tria...

Shares in AC Immune leaped today after the company said its tau-targeting Alzheimer's disease candidate semorinemab hit one of its objectives in a phase 2 trial, although it missed another.

News

US health insurer will not fund Biogen, Eisai's Alzheimer's ...

Health insurer Excellus BlueCross BlueShield has said it will not cover treatment with Biogen and Eisai's new Alzheimer's disease drug Aduhelm because it has not been shown to be medically

News

Closeup of X-ray photography of human brain

Cambridge team says AI could diagnose dementia with one scan

Researchers at Cambridge University in the UK are trialling an artificial intelligence system that they think could spot the signs of dementia after a single brain scan.

News

Lilly sets out its stall on donanemab as filing approaches

The FDA's approval of Biogen's Aduhelm for Alzheimer's disease has emboldened Eli Lilly to move forward plans to file its own candidate donanemab later this year, although it acknowledges i

Startup Neuroglee raises $10m for virtual neurology clinics

Biogen admits slow Aduhelm launch, as scientists question la...

AC Immune claims half a win for tau drug in Alzheimer's tria...

US health insurer will not fund Biogen, Eisai's Alzheimer's ...

Cambridge team says AI could diagnose dementia with one scan

Lilly sets out its stall on donanemab as filing approaches

Lilly's 'triple G' retatrutide aces crucial obesity trial

Discover a new era of healthcare panel engagement: Grounded ...

Alzheimer's disease

Editor's Picks